Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings ...

Cancerguard, a multi-cancer early detection blood test.

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

This series kicks off by introducing David Edelman, Founder & CEO of Thrivable, who joins Pharmaceutical Executive to discuss ...

Alkermes’ $1.50 CVR price is contingent upon approval for Avadel’s leading treatment candidate for idiopathic hypersomnia in ...

David Edelman, Founder & CEO of Thrivable, provides an unflinching look at why today’s most relied-upon tools, including ...

Learn how outdated or incomplete insights turn every decision into a high-stakes gamble that cost brands money, momentum, and ...

Understand how real-time patient intelligence transforms leadership conversations from speculation and opinion battles into ...